Key Words
Adequacy of room cleaning and disinfection using chemical germicides
Rutala WA, Weber DJ, Healthcare Infection Control Practices Advisory Committee. Guideline for disinfection and sterilization in healthcare facilities, 2008. Available from: cdcgov/ncidod/dhqp/pdf/guidelines/Disinfection_Nov_2008pdf. Accessed February 12, 2013.
Rutala WA, Weber DJ, Healthcare Infection Control Practices Advisory Committee. Guideline for disinfection and sterilization in healthcare facilities, 2008. Available from: cdcgov/ncidod/dhqp/pdf/guidelines/Disinfection_Nov_2008pdf. Accessed February 12, 2013.
Low-level disinfectant | Advantages | Disadvantages |
---|---|---|
Alcohol |
|
|
Chlorine |
|
|
Improved hydrogen peroxide |
|
|
Iodophors |
|
|
Phenolics |
|
|
Quaternary ammonium compounds |
|
|
Improving room cleaning/disinfection and demonstrating the effectiveness of surface decontamination in reducing health care-associated infections
- Goodman E.R.
- Platt R.
- Bass R.
- Onderdonk A.B.
- Yokoe D.S.
- Huang S.S.
- Goodman E.R.
- Platt R.
- Bass R.
- Onderdonk A.B.
- Yokoe D.S.
- Huang S.S.
Contact time for disinfection of noncritical surfaces and patient care equipment
Rutala WA, Weber DJ, Healthcare Infection Control Practices Advisory Committee. Guideline for disinfection and sterilization in healthcare facilities, 2008. Available from: cdcgov/ncidod/dhqp/pdf/guidelines/Disinfection_Nov_2008pdf. Accessed February 12, 2013.
Rutala WA, Weber DJ, Healthcare Infection Control Practices Advisory Committee. Guideline for disinfection and sterilization in healthcare facilities, 2008. Available from: cdcgov/ncidod/dhqp/pdf/guidelines/Disinfection_Nov_2008pdf. Accessed February 12, 2013.
- Hidron A.I.
- Edwards J.R.
- Patel J.
- Horan T.C.
- Sievert D.M.
- Pollock D.A.
- et al.
“No Touch” methods for room disinfection
Glosair (formerly Sterinis) | Steris | Bioquell | Tru-D | |
---|---|---|---|---|
Abbreviation | DMHP (dry mist HP) | VHP (vaporized HP) | HPV (HP vapor) | UV-C |
Active agent | 5% hydrogen peroxide, <50 ppm silver cations, <50 ppm ortho-phosphoric acid | Vaprox (35% hydrogen peroxide) | 35% hydrogen peroxide | UV-C irradiation at 254 nm |
Application | Aerosol of active solution | Vapor, noncondensing | Vapor, condensing | UV irradiation; direct and reflected |
Aeration (removal of active agent from enclosure) | Passive decomposition | Active catalytic conversion | Active catalytic conversion | Not necessary |
Sporicidal efficacy | Single cycle does not inactivate Bacillus atrophaeus BIs; ∼4-log10 reduction of C difficile and incomplete inactivation in situ | Inactivation of Geobacillus stearothermophilus BIs | Inactivation of Geobacillus stearothermophilus BIs; >6-log10 reduction of C difficile in vitro and complete inactivation in situ | 1.8- to 4-log10 reduction of C difficile in situ |
Evidence of clinical impact | None published | None published | Significant reduction in the incidence of C difficile | None published |
Lead author, year | HP system | Pathogen | Sites revealing contamination before HPV | Sites revealing contamination after HPV | % Reduction |
---|---|---|---|---|---|
French, 2004 35
Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination. J Hosp Infect. 2004; 57: 31-37 | HPV | MRSA | 61/85-72% | 1/85-1% | 98 |
Bates, 2005 43 | HPV | Serratia | 2/42-5% | 0/24-0% | 100 |
Jeanes, 2005 44 | HPV | MRSA | 10/28-36% | 0/50-0% | 100 |
Otter, 2007 46 | HPV | MRSA | 18/30-60% | 1/30-3% | 95 |
Dryden, 2008 45 | HPV | MRSA | 8/29-28% | 1/29-3% | 88 |
Boyce, 2008 39 | HPV | C difficile | 11/43-26% | 0/37-0% | 100 |
Bartels, 2008 47 | HP dry mist | MRSA | 4/14-29% | 0/14-0% | 100 |
Shapey, 2008 48 | HP dry mist | C difficile | 48/203-24% | 7/203-3% | 88 |
Barbut, 2009 49 | HP dry mist | C difficile | 34/180-19% | 4/180-2% | 88 |
Otter, 2010 50 | HPV | GNR | 10/21-48% | 0/63-0% | 100 |
Ultraviolet irradiation |
---|
Advantages |
|
|
|
|
|
|
|
|
Disadvantages |
|
|
|
|
|
|
|
Decontamination by hydrogen peroxide systems |
Advantages |
|
|
|
|
|
|
|
|
Disadvantages |
|
|
|
|
|
|
|
UV light for room decontamination
HP systems for room decontamination
- French G.L.
- Otter J.A.
- Shannon K.P.
- Adams N.M.T.
- Watling D.
- Parks M.J.
Comparison of UV irradiation versus HP for room decontamination
Conclusion
References
- Are room decontamination units needed to prevent transmission of environmental pathogens?.Infect Control Hosp Epidemiol. 2011; 32: 743-747
- Epidemiology and control of nosocomial infections in adult intensive care units.Am J Med. 1991; 9: S179-S184
- A quantitative approach to defining high-touch surfaces in hospitals.Infect Control Hosp Epidemiol. 2010; 31: 850-853
- Contamination of hands with methicillin-resistant Staphylococcus aureus after contact with environmental surfaces and after contact with the skin of colonized patients.Infect Control Hosp Epidemiol. 2011; 32: 185-187
- Acquisition of spores on gloved hands after contact with the skin of patients with Clostridium difficile infection and with environmental surfaces in their rooms.Am J Infect Control. 2012; 40: 556-558
- Twenty-four hour observational study of hospital hand hygiene compliance.J Hosp Infect. 2010; 76: 252-255
- The role of environmental cleaning in the control of hospital-acquired infection.J Hosp Infect. 2009; 73: 378-385
- Environmental contamination makes an important contribution to hospital infection.J Hosp Infect. 2007; 65: 50-54
- Role of hospital surfaces in the transmission of emerging health care-associated pathogens: Norovirus, Clostridium difficile, and Acinetobacter species.Am J Infect Control. 2010; 38: S25-S33
- Room decontamination by ultraviolet radiation.Infect Control Hosp Epidemiol. 2010; 31: 1025-1029
- How long do nosocomial pathogens persist on inanimate surfaces? A systematic review.BMC Infect Dis. 2006; 6: 130
- Risk of acquiring antibiotic-resistant bacteria from prior room occupants.Arch Int Med. 2006; 166: 1945-1951
- Evaluation of hospital room assignment and acquisition of Clostridium difficile infection.Infect Control Hosp Epidemiol. 2011; 32: 201-206
- The role played by contaminated surfaces in the transmission of nosocomial pathogens.Infect Control Hosp Epidemiol. 2011; 32: 687-699
Rutala WA, Weber DJ, Healthcare Infection Control Practices Advisory Committee. Guideline for disinfection and sterilization in healthcare facilities, 2008. Available from: cdcgov/ncidod/dhqp/pdf/guidelines/Disinfection_Nov_2008pdf. Accessed February 12, 2013.
- Identifying opportunities to enhance environmental cleaning in 23 acute care hospitals.Infect Control Hosp Epidemiol. 2008; 29: 1-7
- Intensive care unit environmental cleaning: an evaluation in sixteen hospitals using a novel assessment tool.J Hosp Infect. 2008; 68: 39-44
- Cleanliness of portable medical equipment disinfected by nursing staff.Am J Infect Control. 2011; 39: 602-604
- Efficacy of improved hydrogen peroxide against important healthcare-associated pathogens.Infect Control Hosp Epidemiol. 2012; 33: 1159-1161
- Efficacy of different “cleaning/disinfection” methods against Clostridium difficile spores: importance of physical removal versus sporicidal inactivation.Infect Control Hosp Epidemiol. 2012; 33: 1255-1258
- Improving environmental hygiene in 27 intensive care units to decrease multidrug-resistant bacterial transmission.Crit Care Med. 2010; 38: 1054-1059
- Improving cleaning of the environment surrounding patients in 36 acute care hospitals.Infect Control Hosp Epidemiol. 2008; 29: 1035-1041
- A modified ATP benchmark for evaluating the cleaning of some hospital environmental surfaces.J Hosp Infect. 2008; 69: 156-163
- Intervention evaluation of environmental contamination by vancomycin-resistant enterococci: failure of personnel, product, or procedure?.J Hosp Infect. 2009; 71: 123-131
- Impact of an environmental cleaning intervention on the presence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on surfaces in intensive care unit rooms.Infect Control Hosp Epidemiol. 2008; 29: 593-599
- Reduction of Clostridium difficile and vancomycin-resistant Enterococcus contamination of environmental surfaces after an intervention to improve cleaning methods.BMC Infect Dis. 2007; 7: 61
- Microbial assessment of high, medium, and low-touch hospital room surfaces.Infect Control Hosp Epidemiol. 2013; 34: 211-212
- Relative frequency of healthcare-associated pathogens by infection site at a university hospital from 1980-2008.Am J Infect Control. 2012; 40: 416-420
- Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007.Infect Control Hosp Epidemiol. 2008; 29: 996-1011
- Gaseous and air decontamination technologies for Clostridium difficile in the healthcare environment.J Hosp Infect. 2011; 77: 199-203
- Sterilization, high-level disinfection, and environmental cleaning.Infect Dis Clin N Am. 2011; 25: 45-76
- Applications of ultraviolet germicidal irradiation disinfection in health care facilities: effective adjunct, but not stand-alone technology.Am J Infect Control. 2010; 38: S13-S24
- Terminal decontamination of patient rooms using an automated mobile UV light unit.Infect Control Hosp Epidemiol. 2011; 32: 743-747
- Evaluation of an automated ultraviolet radiation device for decontamination of Clostridium difficile and other healthcare-associated pathogens in hospital rooms.BMC Infect Dis. 2010; 10: 197
- Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination.J Hosp Infect. 2004; 57: 31-37
- Airborne hydrogen peroxide for disinfection of the hospital environment and infection control: a systematic review.J Hosp Infect. 2011; 78: 171-177
- Use of hydrogen peroxide vapor for deactivation of Mycobacterium tuberculosis in a biological safety cabinet and a room.J Clin Microbiol. 2007; 45: 810-815
- Hydrogen peroxide vapour decontamination of surfaces artifically contaminated with norovirus surrogate feline calicivirus.J Hosp Infect. 2012; 80: 116-121
- Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting.Infect Control Hosp Epidemiol. 2008; 29: 723-729
- An evaluation of environmental decontamination with hydrogen peroxide vapor for reducing the risk of patient acquisition of multidrug-resistant organisms.Clin Infect Dis. 2013; 56: 27-35
- Feasibility of routinely using hydrogen peroxide vapor to decontaminate rooms in a busy United States hospital.Infect Control Hosp Epidemiol. 2009; 30: 574-577
- A call for clarity when discussing hydrogen peroxide vapour and aerosol systems.J Hosp Infect. 2011; 77: 83
- Use of hydrogen peroxide vapour for environmental control during a Serratia outbreak in a neonatal intensive care unit.J Hosp Infect. 2005; 61: 364-366
- Eradication of persistent environmental MRSA.J Hosp Infect. 2005; 61: 85-86
- Hydrogen peroxide vapour decontamination in the control of a polyclonal methicillin-resistant Staphylococcus aureus outbreak on a surgical ward.J Hosp Infect. 2008; 68: 190-192
- Assessing the biological efficacy and rate of recontamination following hydrogen peroxide vapour decontamination.J Hosp Infect. 2007; 67: 182-188
- Environmental methicillin-resistant Staphylococcus aureus (MRSA) disinfection using dry-mist-generated hydrogen peroxide.J Hosp Infect. 2008; 70: 35-41
- Activity of a dry mist hydrogen peroxide system against environmental Clostridium difficile contamination in elderly care wards.J Hosp Infect. 2008; 70: 136-141
- Comparison of the efficacy of a hydrogen peroxide dry-mist disinfection system and sodium hypochlorite solution for eradication of Clostridium difficile spores.Infect Control Hosp Epidemiol. 2009; 30: 515-517
- Hydrogen peroxide vapor decontamination of an intensive care unit to remove environmental reservoirs of multidrug-resistant gram-negative rods during an outbreak.Am J Infect Control. 2010; 38: 754-756
Article info
Footnotes
Publication of this article was supported by Advanced Sterilization Products (ASP).
Conflicts of interest: W.A.R. provides consultation to Advanced Sterilization Products and Clorox, and D.J.W. provides consultative service to Clorox.